Do the beneficial effects of extended methylphenidate treatment in boys with attention-deficit hyperactivity disorder dissipate rapidly during placebo treatment?

Author：  

Publisher： Informa Healthcare

ISSN： 0803-9488

Source： Nordic Journal of Psychiatry, Vol.53, Iss.1, 1999-03, pp. : 55-60

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder

By Rösler Michael   Fischer Roland   Ammer Richard   Ose Claudia   Retz Wolfgang  

European Archives of Psychiatry and Clinical Neuroscience, Vol. 259, Iss. 2, 2009-02 ,pp. : 120-129

Springer Publishing Company

Access to resources Recommend Favorite

Mixed amphetamine salts extended release: a clinical review of its use in the treatment of attention-deficit hyperactivity disorder

By Grcevich Stephen  

Future Neurology, Vol. 1, Iss. 5, 2006-09 ,pp. : 525-534

Future Medicine

Access to resources Recommend Favorite

Buspirone Versus Methylphenidate in the Treatment of Attention Deficit Hyperactivity Disorder: A Double-Blind and Randomized Trial

By Davari-Ashtiani Rozita  

Child Psychiatry and Human Development, Vol. 41, Iss. 6, 2010-12 ,pp. : 641-648

Springer Publishing Company

Access to resources Recommend Favorite

Attention-deficit/hyperactivity disorder: cognitive evoked potential (P300) topography predicts treatment response to methylphenidate

By Sangal J.M.   Sangal R.B.  

Clinical Neurophysiology, Vol. 115, Iss. 1, 2004-01 ,pp. : 188-193

Elsevier

Access to resources Recommend Favorite

Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis And Treatment

By Thomas J. Lawrence  

Archives of Clinical Neuropsychology, Vol. 23, Iss. 5, 2008-09 ,pp. : 623-625

Oxford University Press

Access to resources Recommend Favorite